Transcriptional Regulation by MECP2
Feldman D, Banerjee A, Sur M. Developmental Dynamics of Rett Syndrome. Neural Plast. 2016;2016():6154080. PMID: 26942018; PMCID: PMC4752981.; Leong WY, Lim ZH, Korzh V, Pietri T, Goh ELK. Methyl-CpG Binding Protein 2 (Mecp2) Regulates Sensory Function Through Sema5b and Robo2. Front. Cell. Neurosci. 2015 Dec 21;9(). doi: 10.3389/fncel.2015.00481.; Sztainberg Y, Chen HM, Swann JW, Hao S, Tang B, Wu Z, Tang J, Wan YW, Liu Z, Rigo F, Zoghbi HY. Reversal of phenotypes in MECP2 duplication mice using genetic rescue or antisense oligonucleotides. Nature. 2015 Dec 03;528(7580):123–6. PMID: 26605526; PMCID: PMC4839300.; Tsujimura K, Irie K, Nakashima H, Egashira Y, Fukao Y, Fujiwara M, Itoh M, Uesaka M, Imamura T, Nakahata Y, Yamashita Y, Abe T, Takamori S, Nakashima K. miR-199a Links MeCP2 with mTOR Signaling and Its Dysregulation Leads to Rett Syndrome Phenotypes. Cell Rep. 2015 Sep 22;12(11):1887–901. doi: 10.1016/j.celrep.2015.08.028. PMID: 26344767.; Krishnan N, Krishnan K, Connors CR, Choy MS, Page R, Peti W, Van Aelst L, Shea SD, Tonks NK. PTP1B inhibition suggests a therapeutic strategy for Rett syndrome. J Clin Invest. 2015 Aug 03;125(8):3163–77. PMID: 26214522; PMCID: PMC4563751.; Chen L, Chen K, Lavery LA, Baker SA, Shaw CA, Li W, Zoghbi HY. MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome. Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5509–14. PMID: 25870282; PMCID: PMC4418849.; KhorshidAhmad T, Acosta C, Cortes C, Lakowski TM, Gangadaran S, Namaka M. Transcriptional Regulation of Brain-Derived Neurotrophic Factor (BDNF) by Methyl CpG Binding Protein 2 (MeCP2): a Novel Mechanism for Re-Myelination and/or Myelin Repair Involved in the Treatment of Multiple Sclerosis (MS). Mol Neurobiol. 2016 Mar;53(2):1092–107. doi: 10.1007/s12035-014-9074-1. PMID: 25579386.; Williamson SL, Ellaway CJ, Peters GB, Pelka GJ, Tam PP, Christodoulou J. Deletion of protein tyrosine phosphatase, non-receptor type 4 (PTPN4) in twins with a Rett syndrome-like phenotype. European Journal of Human Genetics. 2014 Nov 26;23(9):1171–5. doi: 10.1038/ejhg.2014.249.; Li H, Zhong X, Chau KF, Santistevan NJ, Guo W, Kong G, Li X, Kadakia M, Masliah J, Chi J, Jin P, Zhang J, Zhao X, Chang Q. Cell cycle-linked MeCP2 phosphorylation modulates adult neurogenesis involving the Notch signalling pathway. Nature Communications. 2014 Nov 25;5(1):5601. doi: 10.1038/ncomms6601.; He LJ, Liu N, Cheng TL, Chen XJ, Li YD, Shu YS, Qiu ZL, Zhang XH. Conditional deletion of Mecp2 in parvalbumin-expressing GABAergic cells results in the absence of critical period plasticity. Nat Commun. 2014 Oct 09;5():5036. doi: 10.1038/ncomms6036. PMID: 25297674.; Livide G, Patriarchi T, Amenduni M, Amabile S, Yasui D, Calcagno E, Lo Rizzo C, De Falco G, Ulivieri C, Ariani F, Mari F, Mencarelli MA, Hell JW, Renieri A, Meloni I. GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells. European Journal of Human Genetics. 2014 Jun 11;23(2):195–201. doi: 10.1038/ejhg.2014.81.; Orlic-Milacic M, Kaufman L, Mikhailov A, Cheung AYL, Mahmood H, Ellis J, Gianakopoulos PJ, Minassian BA, Vincent JB. Over-Expression of Either MECP2_e1 or MECP2_e2 in Neuronally Differentiated Cells Results in Different Patterns of Gene Expression. PLoS ONE. 2014 Apr 03;9(4):e91742. doi: 10.1371/journal.pone.0091742.; Cheng TL, Wang Z, Liao Q, Zhu Y, Zhou WH, Xu W, Qiu Z. MeCP2 suppresses nuclear microRNA processing and dendritic growth by regulating the DGCR8/Drosha complex. Dev Cell. 2014 Mar 10;28(5):547–60. doi: 10.1016/j.devcel.2014.01.032. PMID: 24636259.; Olson CO, Zachariah RM, Ezeonwuka CD, Liyanage VRB, Rastegar M. Brain Region-Specific Expression of MeCP2 Isoforms Correlates with DNA Methylation within Mecp2 Regulatory Elements. PLoS ONE. 2014 Mar 03;9(3):e90645. doi: 10.1371/journal.pone.0090645.; Li W, Pozzo-Miller L. BDNF deregulation in Rett syndrome. Neuropharmacology. 2014 Jan;76 Pt C():737–46. PMID: 23597512; PMCID: PMC3773283.; Yasui DH, Gonzales ML, Aflatooni JO, Crary FK, Hu DJ, Gavino BJ, Golub MS, Vincent JB, Carolyn Schanen N, Olson CO, Rastegar M, Lasalle JM. Mice with an isoform-ablating Mecp2 exon 1 mutation recapitulate the neurologic deficits of Rett syndrome. Hum Mol Genet. 2014 May 01;23(9):2447–58. PMID: 24352790; PMCID: PMC3976336.; Liyanage VR, Zachariah RM, Rastegar M. Decitabine alters the expression of Mecp2 isoforms via dynamic DNA methylation at the Mecp2 regulatory elements in neural stem cells. Molecular Autism. 2013 Nov 15;4(1):46. doi: 10.1186/2040-2392-4-46.; Plummer JT, Evgrafov OV, Bergman MY, Friez M, Haiman CA, Levitt P, Aldinger KA. Transcriptional regulation of the MET receptor tyrosine kinase gene by MeCP2 and sex-specific expression in autism and Rett syndrome. Transl Psychiatry. 2013 Oct 22;3():e316. PMID: 24150225; PMCID: PMC3818007.; Kaddoum L, Panayotis N, Mazarguil H, Giglia-Mari G, Roux JC, Joly E. Isoform-specific anti-MeCP2 antibodies confirm that expression of the e1 isoform strongly predominates in the brain. F1000Res. 2013 Oct 04;2():204. doi: 10.12688/f1000research.2-204.v1.; Li Y, Wang H, Muffat J, Cheng AW, Orlando DA, Lovén J, Kwok SM, Feldman DA, Bateup HS, Gao Q, Hockemeyer D, Mitalipova M, Lewis CA, Vander Heiden MG, Sur M, Young RA, Jaenisch R. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. Cell Stem Cell. 2013 Oct 03;13(4):446–58. PMID: 24094325; PMCID: PMC4053296.; Ebert DH, Gabel HW, Robinson ND, Kastan NR, Hu LS, Cohen S, Navarro AJ, Lyst MJ, Ekiert R, Bird AP, Greenberg ME. Activity-dependent phosphorylation of MeCP2 threonine 308 regulates interaction with NCoR. Nature. 2013 Jul 18;499(7458):341–5. PMID: 23770587; PMCID: PMC3922283.; Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J, Guy J, Kastan NR, Robinson ND, de Lima Alves F, Rappsilber J, Greenberg ME, Bird A. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat Neurosci. 2013 Jul;16(7):898–902. PMID: 23770565; PMCID: PMC3786392.; Chen Y, Shin BC, Thamotharan S, Devaskar SU. Creb1-Mecp2-(m)CpG complex transactivates postnatal murine neuronal glucose transporter isoform 3 expression. Endocrinology. 2013 Apr;154(4):1598–611. PMID: 23493374; PMCID: PMC3602632.; Ebert DH, Greenberg ME. Activity-dependent neuronal signalling and autism spectrum disorder. Nature. 2013 Jan 17;493(7432):327–37. PMID: 23325215; PMCID: PMC3576027.; Mellén M, Ayata P, Dewell S, Kriaucionis S, Heintz N. MeCP2 binds to 5hmC enriched within active genes and accessible chromatin in the nervous system. Cell. 2012 Dec 21;151(7):1417–30. PMID: 23260135; PMCID: PMC3653293.; Durand S, Patrizi A, Quast KB, Hachigian L, Pavlyuk R, Saxena A, Carninci P, Hensch TK, Fagiolini M. NMDA receptor regulation prevents regression of visual cortical function in the absence of Mecp2. Neuron. 2012 Dec 20;76(6):1078–90. PMID: 23259945; PMCID: PMC3733788.; Li W, Calfa G, Larimore J, Pozzo-Miller L. Activity-dependent BDNF release and TRPC signaling is impaired in hippocampal neurons of Mecp2 mutant mice. Proc. Natl. Acad. Sci. U.S.A. 2012 Oct;109(42):17087–92. doi: 10.1073/pnas.1205271109.; Van Esch H. MECP2 Duplication Syndrome. Mol Syndromol. 2012 Apr;2(3-5):128–36. PMID: 22679399; PMCID: PMC3366699.; Qiu Z, Sylwestrak EL, Lieberman DN, Zhang Y, Liu X, Ghosh A. The Rett Syndrome Protein MeCP2 Regulates Synaptic Scaling. J. Neurosci. 2012 Jan 18;32(3):989–94. doi: 10.1523/jneurosci.0175-11.2012.; Samaco RC, Mandel-Brehm C, McGraw CM, Shaw CA, McGill BE, Zoghbi HY. Crh and Oprm1 mediate anxiety-related behavior and social approach in a mouse model of MECP2 duplication syndrome. Nat Genet. 2012 Jan 08;44(2):206–11. PMID: 22231481; PMCID: PMC3267865.; Gianakopoulos PJ, Zhang Y, Pencea N, Orlic-Milacic M, Mittal K, Windpassinger C, White S, Kroisel PM, Chow EWC, Saunders CJ, Minassian BA, Vincent JB. Mutations in MECP2 exon 1 in classical rett patients disrupt MECP2_e1 transcription, but not transcription of MECP2_e2. American J of Med Genetics Pt B. 2011 Dec 27;159B(2):210–6. doi: 10.1002/ajmg.b.32015.; Kerr B, Soto C J, Saez M, Abrams A, Walz K, Young JI. Transgenic complementation of MeCP2 deficiency: phenotypic rescue of Mecp2-null mice by isoform-specific transgenes. European Journal of Human Genetics. 2011 Aug 10;20(1):69–76. doi: 10.1038/ejhg.2011.145.; Lioy DT, Garg SK, Monaghan CE, Raber J, Foust KD, Kaspar BK, Hirrlinger PG, Kirchhoff F, Bissonnette JM, Ballas N, Mandel G. A role for glia in the progression of Rett's syndrome. Nature. 2011 Jun 29;475(7357):497–500. PMID: 21716289; PMCID: PMC3268776.; Joss-Moore LA, Wang Y, Ogata EM, Sainz AJ, Yu X, Callaway CW, McKnight RA, Albertine KH, Lane RH. IUGR differentially alters MeCP2 expression and H3K9Me3 of the PPAR? gene in male and female rat lungs during alveolarization. Birth Defects Res A Clin Mol Teratol. 2011 Aug;91(8):672–81. PMID: 21425435; PMCID: PMC3152656.; Ricciardi S, Boggio EM, Grosso S, Lonetti G, Forlani G, Stefanelli G, Calcagno E, Morello N, Landsberger N, Biffo S, Pizzorusso T, Giustetto M, Broccoli V. Reduced AKT/mTOR signaling and protein synthesis dysregulation in a Rett syndrome animal model. Hum Mol Genet. 2011 Mar 15;20(6):1182–96. doi: 10.1093/hmg/ddq563. PMID: 21212100.; Chao HT, Chen H, Samaco RC, Xue M, Chahrour M, Yoo J, Neul JL, Gong S, Lu HC, Heintz N, Ekker M, Rubenstein JL, Noebels JL, Rosenmund C, Zoghbi HY. Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature. 2010 Nov 11;468(7321):263–9. PMID: 21068835; PMCID: PMC3057962.; Franklin TB, Russig H, Weiss IC, Gräff J, Linder N, Michalon A, Vizi S, Mansuy IM. Epigenetic transmission of the impact of early stress across generations. Biol Psychiatry. 2010 Sep 01;68(5):408–15. doi: 10.1016/j.biopsych.2010.05.036. PMID: 20673872.; Hwang CK, Kim CS, Kim DK, Law P, Wei L, Loh HH. Up-Regulation of the µ-Opioid Receptor Gene Is Mediated through Chromatin Remodeling and Transcriptional Factors in Differentiated Neuronal Cells. Molecular Pharmacology. 2010 Jul;78(1):58–68. doi: 10.1124/mol.110.064311.; Maezawa I, Jin L. Rett Syndrome Microglia Damage Dendrites and Synapses by the Elevated Release of Glutamate. J. Neurosci. 2010 Apr 14;30(15):5346–56. doi: 10.1523/jneurosci.5966-09.2010.; Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA. MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology. 2010 Feb;138(2):705–14, 714.e1. PMID: 19843474; PMCID: PMC2819585.; Degano AL, Pasterkamp RJ, Ronnett GV. MeCP2 deficiency disrupts axonal guidance, fasciculation, and targeting by altering Semaphorin 3F function. Molecular and Cellular Neuroscience. 2009 Oct;42(3):243–54. doi: 10.1016/j.mcn.2009.07.009.; Hwang CK, Song KY, Kim CS, Choi HS, Guo X, Law P, Wei L, Loh HH. Epigenetic programming of µ-opioid receptor gene in mouse brain is regulated by MeCP2 and brg1 chromatin remodelling factor. J Cellular Molecular Medi. 2009 Sep;13(9b):3591–615. doi: 10.1111/j.1582-4934.2008.00535.x.; Tao J, Hu K, Chang Q, Wu H, Sherman NE, Martinowich K, Klose RJ, Schanen C, Jaenisch R, Wang W, Sun YE. Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4882–7. PMID: 19225110; PMCID: PMC2660725.; Tropea D, Giacometti E, Wilson NR, Beard C, McCurry C, Fu DD, Flannery R, Jaenisch R, Sur M. Partial reversal of Rett Syndrome-like symptoms in MeCP2 mutant mice. Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):2029–34. PMID: 19208815; PMCID: PMC2644158.; Urdinguio RG, Lopez-Serra L, Lopez-Nieva P, Alaminos M, Diaz-Uriarte R, Fernandez AF, Esteller M. Mecp2-Null Mice Provide New Neuronal Targets for Rett Syndrome. PLoS ONE. 2008 Nov 07;3(11):e3669. doi: 10.1371/journal.pone.0003669.; Nagarajan RP, Patzel KA, Martin M, Yasui DH, Swanberg SE, Hertz-Picciotto I, Hansen RL, Van de Water J, Pessah IN, Jiang R, Robinson WP, LaSalle JM. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Res. 2008 Jun;1(3):169–78. PMID: 19132145; PMCID: PMC2614877.; Chahrour M, Jung SY, Shaw C, Zhou X, Wong ST, Qin J, Zoghbi HY. MeCP2, a key contributor to neurological disease, activates and represses transcription. Science. 2008 May 30;320(5880):1224–9. PMID: 18511691; PMCID: PMC2443785.; Guy J, Gan J, Selfridge J, Cobb S, Bird A. Reversal of neurological defects in a mouse model of Rett syndrome. Science. 2007 Feb 23;315(5815):1143–7. PMID: 17289941; PMCID: PMC7610836.; Dragich JM, Kim Y, Arnold AP, Schanen NC. Differential distribution of the MeCP2 splice variants in the postnatal mouse brain. J of Comparative Neurology. 2007 Feb 02;501(4):526–42. doi: 10.1002/cne.21264.; McGill BE, Bundle SF, Yaylaoglu MB, Carson JP, Thaller C, Zoghbi HY. Enhanced anxiety and stress-induced corticosterone release are associated with increased Crh expression in a mouse model of Rett syndrome. Proc. Natl. Acad. Sci. U.S.A. 2006 Nov 28;103(48):18267–72. doi: 10.1073/pnas.0608702103.; Hu K, Nan X, Bird A, Wang W. Testing for association between MeCP2 and the brahma-associated SWI/SNF chromatin-remodeling complex. Nat Genet. 2006 Sep;38(9):962–4; author reply 964. doi: 10.1038/ng0906-962. PMID: 16940996.; Van Esch H, Bauters M, Ignatius J, Jansen M, Raynaud M, Hollanders K, Lugtenberg D, Bienvenu T, Jensen LR, Gécz J, Moraine C, Marynen P, Fryns J, Froyen G. Duplication of the MECP2 Region Is a Frequent Cause of Severe Mental Retardation and Progressive Neurological Symptoms in Males. The American Journal of Human Genetics. 2005 Sep;77(3):442–53. doi: 10.1086/444549.; Nuber UA, Kriaucionis S, Roloff TC, Guy J, Selfridge J, Steinhoff C, Schulz R, Lipkowitz B, Ropers HH, Holmes MC, Bird A. Up-regulation of glucocorticoid-regulated genes in a mouse model of Rett syndrome. Hum Mol Genet. 2005 Aug 01;14(15):2247–56. doi: 10.1093/hmg/ddi229. PMID: 16002417.; Harikrishnan KN, Chow MZ, Baker EK, Pal S, Bassal S, Brasacchio D, Wang L, Craig JM, Jones PL, Sif S, El-Osta A. Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing. Nat Genet. 2005 Mar;37(3):254–64. doi: 10.1038/ng1516. PMID: 15696166.; Collins AL, Levenson JM, Vilaythong AP, Richman R, Armstrong DL, Noebels JL, David Sweatt J, Zoghbi HY. Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet. 2004 Nov 01;13(21):2679–89. doi: 10.1093/hmg/ddh282. PMID: 15351775.; Luikenhuis S, Giacometti E, Beard CF, Jaenisch R. Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl. Acad. Sci. U.S.A. 2004 Apr 06;101(16):6033–8. doi: 10.1073/pnas.0401626101.; Mnatzakanian GN, Lohi H, Munteanu I, Alfred SE, Yamada T, MacLeod PJ, Jones JR, Scherer SW, Schanen NC, Friez MJ, Vincent JB, Minassian BA. A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome. Nat Genet. 2004 Apr;36(4):339–41. doi: 10.1038/ng1327. PMID: 15034579.; Kriaucionis S, Bird A. The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucleic Acids Res. 2004;32(5):1818–23. PMID: 15034150; PMCID: PMC390342.; Yoon HG, Chan DW, Reynolds AB, Qin J, Wong J. N-CoR mediates DNA methylation-dependent repression through a methyl CpG binding protein Kaiso. Mol Cell. 2003 Sep;12(3):723–34. doi: 10.1016/j.molcel.2003.08.008. PMID: 14527417.; Kimura H, Shiota K. Methyl-CpG-binding Protein, MeCP2, Is a Target Molecule for Maintenance DNA Methyltransferase, Dnmt1. Journal of Biological Chemistry. 2003 Feb;278(7):4806–12. doi: 10.1074/jbc.m209923200.; Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN, Bird A. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature. 1998 May 28;393(6683):386–9. doi: 10.1038/30764. PMID: 9620804.